s6y

4 Molecular Insight Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001209191-07-063189

Documents

  1. FORM 4 SUBMISSION 4
  2. FORM 4 SUBMISSION 4
  3. POA DOCUMENT EX-24.4_210711

On sec.gov